vs
Side-by-side financial comparison of MARINE PRODUCTS CORP (MPX) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $64.6M, roughly 1.4× MARINE PRODUCTS CORP). Vericel Corp runs the higher net margin — 25.0% vs 3.7%, a 21.4% gap on every dollar of revenue. On growth, MARINE PRODUCTS CORP posted the faster year-over-year revenue change (35.0% vs 23.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $4.1M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -3.5%).
West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
MPX vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.6M | $92.9M |
| Net Profit | $2.4M | $23.2M |
| Gross Margin | 19.6% | 78.7% |
| Operating Margin | 5.8% | 24.1% |
| Net Margin | 3.7% | 25.0% |
| Revenue YoY | 35.0% | 23.3% |
| Net Profit YoY | -44.6% | 17.3% |
| EPS (diluted) | $0.07 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $64.6M | $92.9M | ||
| Q3 25 | $53.1M | $67.5M | ||
| Q2 25 | $67.7M | $63.2M | ||
| Q1 25 | $59.0M | $52.6M | ||
| Q4 24 | $47.8M | $75.4M | ||
| Q3 24 | $49.9M | $57.9M | ||
| Q2 24 | $69.5M | $52.7M | ||
| Q1 24 | $69.3M | $51.3M |
| Q4 25 | $2.4M | $23.2M | ||
| Q3 25 | $2.6M | $5.1M | ||
| Q2 25 | $4.2M | $-553.0K | ||
| Q1 25 | $2.2M | $-11.2M | ||
| Q4 24 | $4.3M | $19.8M | ||
| Q3 24 | $3.4M | $-901.0K | ||
| Q2 24 | $5.6M | $-4.7M | ||
| Q1 24 | $4.6M | $-3.9M |
| Q4 25 | 19.6% | 78.7% | ||
| Q3 25 | 19.2% | 73.5% | ||
| Q2 25 | 19.1% | 73.7% | ||
| Q1 25 | 18.6% | 69.0% | ||
| Q4 24 | 19.2% | 77.6% | ||
| Q3 24 | 18.4% | 71.9% | ||
| Q2 24 | 18.9% | 69.5% | ||
| Q1 24 | 20.2% | 68.9% |
| Q4 25 | 5.8% | 24.1% | ||
| Q3 25 | 5.4% | 5.1% | ||
| Q2 25 | 7.1% | -3.2% | ||
| Q1 25 | 4.4% | -24.3% | ||
| Q4 24 | 7.7% | 24.5% | ||
| Q3 24 | 7.2% | -4.3% | ||
| Q2 24 | 8.3% | -11.5% | ||
| Q1 24 | 7.6% | -10.7% |
| Q4 25 | 3.7% | 25.0% | ||
| Q3 25 | 5.0% | 7.5% | ||
| Q2 25 | 6.1% | -0.9% | ||
| Q1 25 | 3.7% | -21.4% | ||
| Q4 24 | 8.9% | 26.3% | ||
| Q3 24 | 6.8% | -1.6% | ||
| Q2 24 | 8.0% | -8.9% | ||
| Q1 24 | 6.6% | -7.5% |
| Q4 25 | $0.07 | $0.46 | ||
| Q3 25 | $0.07 | $0.10 | ||
| Q2 25 | $0.12 | $-0.01 | ||
| Q1 25 | $0.06 | $-0.23 | ||
| Q4 24 | $0.13 | $0.40 | ||
| Q3 24 | $0.10 | $-0.02 | ||
| Q2 24 | $0.14 | $-0.10 | ||
| Q1 24 | $0.13 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $125.0M | $354.6M |
| Total Assets | $147.2M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $125.0M | $354.6M | ||
| Q3 25 | $126.3M | $321.9M | ||
| Q2 25 | $127.2M | $306.8M | ||
| Q1 25 | $126.4M | $295.5M | ||
| Q4 24 | $129.0M | $292.0M | ||
| Q3 24 | $128.8M | $257.5M | ||
| Q2 24 | $129.3M | $243.0M | ||
| Q1 24 | $151.4M | $233.9M |
| Q4 25 | $147.2M | $488.0M | ||
| Q3 25 | $179.5M | $453.3M | ||
| Q2 25 | $173.2M | $435.6M | ||
| Q1 25 | $182.9M | $424.6M | ||
| Q4 24 | $171.2M | $432.7M | ||
| Q3 24 | $176.3M | $390.4M | ||
| Q2 24 | $175.7M | $376.8M | ||
| Q1 24 | $204.0M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.7M | $15.0M |
| Free Cash FlowOCF − Capex | $4.1M | $12.8M |
| FCF MarginFCF / Revenue | 6.4% | 13.8% |
| Capex IntensityCapex / Revenue | 0.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.00× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $14.9M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.7M | $15.0M | ||
| Q3 25 | $2.6M | $22.1M | ||
| Q2 25 | $-1.6M | $8.2M | ||
| Q1 25 | $10.8M | $6.6M | ||
| Q4 24 | $4.6M | $22.2M | ||
| Q3 24 | $5.1M | $10.2M | ||
| Q2 24 | $3.8M | $18.5M | ||
| Q1 24 | $15.9M | $7.2M |
| Q4 25 | $4.1M | $12.8M | ||
| Q3 25 | $2.1M | $19.5M | ||
| Q2 25 | $-2.0M | $81.0K | ||
| Q1 25 | $10.7M | $-7.6M | ||
| Q4 24 | $3.6M | $8.5M | ||
| Q3 24 | $3.2M | $-9.2M | ||
| Q2 24 | $3.0M | $1.8M | ||
| Q1 24 | $15.0M | $-6.8M |
| Q4 25 | 6.4% | 13.8% | ||
| Q3 25 | 4.0% | 28.8% | ||
| Q2 25 | -3.0% | 0.1% | ||
| Q1 25 | 18.1% | -14.5% | ||
| Q4 24 | 7.6% | 11.2% | ||
| Q3 24 | 6.5% | -15.9% | ||
| Q2 24 | 4.4% | 3.4% | ||
| Q1 24 | 21.7% | -13.3% |
| Q4 25 | 0.9% | 2.4% | ||
| Q3 25 | 0.8% | 3.9% | ||
| Q2 25 | 0.6% | 12.9% | ||
| Q1 25 | 0.2% | 27.0% | ||
| Q4 24 | 2.1% | 18.3% | ||
| Q3 24 | 3.8% | 33.5% | ||
| Q2 24 | 1.1% | 31.8% | ||
| Q1 24 | 1.3% | 27.3% |
| Q4 25 | 2.00× | 0.65× | ||
| Q3 25 | 0.97× | 4.35× | ||
| Q2 25 | -0.39× | — | ||
| Q1 25 | 4.88× | — | ||
| Q4 24 | 1.09× | 1.12× | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 3.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MPX
| Boats And Accessories | $63.4M | 98% |
| Parts | $1.1M | 2% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
